The combination of WEE1 and CHK1 inhibitors demonstrated a synergistic inhibitory effect on the growth of B and T cell precursor acute lymphoblastic leukaemia (B/T-ALL) tumors and induced tumor cells to enter apoptosis [100]. The gene discussed is CHEK1; the disease is acute lymphoblastic leukemia.